After a public comment period, the U.S. Federal Trade Commission (FTC) has approved a final order settling claims that L’Oréal USA , Inc. deceptively advertised its Lancôme Genifique and L’Oréal Paris Youth Code anti-aging skincare products as clinically proven to reduce the effects of aging by targeting users’ genes. In re L’Oréal USA, No. 122 3016 (FTC, approval entered September 24, 2014). Under the agreement, L’Oréal cannot claim that any Lancome or L’Oréal Paris brand skincare product “boosts the activity of genes or targets specific genes, thereby [r]esulting in skin that looks younger or acts younger; or [c]ausing skin to respond five times faster to aggressors such as stress, fatigue, and aging.” Additional information about the complaint and settlement appears in Issue 28 of this Report. See FTC Press Release, September 26, 2014.